Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.

Estrada V, Monge S, Gómez-Garre MD, Sobrino P, Masiá M, Berenguer J, Portilla J, Viladés C, Martínez E, Blanco JR; CoRIS and the HIV Biobank integrated in the Spanish AIDS Research Network.

HIV Med. 2016 Mar 3. doi: 10.1111/hiv.12368. [Epub ahead of print]

PMID:
26935006
2.

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.

Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, Bernal E, Asensi V, Pulido F, Del Amo J, Hernando V; Cohorte de la Red de Investigación en Sida, Spain.

J Infect. 2016 May;72(5):587-96. doi: 10.1016/j.jinf.2016.01.017. Epub 2016 Feb 24.

3.

Description and consequences of prescribing off-label antiretrovirals in the Madrid Cohort of HIV-infected children over a quarter of a century (1988-2012).

Fernández-Cooke E, Rojas P, Holguin A, Tomé MI, Jimenez de Ory S, Mellado MJ, Navarro ML, Rojo P, Ramos JT.

Antivir Ther. 2016;21(1):65-70. doi: 10.3851/IMP2973. Epub 2015 Jun 16.

PMID:
26079937
4.

Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.

Blázquez D, Ramos-Amador JT, Saínz T, Mellado MJ, García-Ascaso M, De José MI, Rojo P, Navarro ML, Muñoz-Fernández MÁ, Saavedra J, Roa MA, Jiménez S, Beceiro J, Prieto L, Hortelano MG, González-Tomé MI.

BMC Infect Dis. 2015 Mar 8;15:119. doi: 10.1186/s12879-015-0853-8.

5.

Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy.

Sainz T, Álvarez-Fuente M, Fernández-Jiménez R, González-Tomé MI, de José MI, Ramos JT, Navarro ML, Martínez J, García-Hortelano M, Medrano C, Muñoz-Fernández MÁ, Mellado MJ; Madrid Cohort of HIV-Infected Children and Adolescents Integrated in the Pediatric Branch of the Spanish National AIDS Network (CoRISpeS).

Pediatr Infect Dis J. 2015 May;34(5):e125-31. doi: 10.1097/INF.0000000000000634.

PMID:
25876103
6.

Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012.

Palladino C, Briz V, Bellón JM, Climent FJ, de Ory SJ, Mellado MJ, Navarro ML, Ramos JT, Taveira N, de José MI, Muñoz-Fernández MÁ; CoRISpeS-Madrid Cohort Working Group.

PLoS One. 2014 May 1;9(5):e96307. doi: 10.1371/journal.pone.0096307. eCollection 2014.

7.

Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescents.

Sainz T, Ortega-Hernández A, Serrano-Villar S, Navarro ML, Rojo P, Ramos JT, Mellado MJ, Diaz L, Alvarez M, Estrada V, Gómez-Garre D, Muñoz-Fernández MA; Madrid Cohort of HIV-infected children and adolescents, integrating the Pediatric branch of the National AIDS Research Network of Spain (CoRISpE).

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):265-9. doi: 10.1097/QAI.0000000000000160.

PMID:
24732875
8.

Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities.

Sainz T, Diaz L, Navarro ML, Rojo P, Blázquez D, Ramos JT, de José MI, Álvarez-Fuente M, Serrano-Villar S, Mellado MJ, Muñoz-Fernández MA; Madrid Cohort of HIV-infected children and adolescents, integrating the Pediatric branch of the National AIDS Research Network of Spain (CORISPE).

Atherosclerosis. 2014 Apr;233(2):410-4. doi: 10.1016/j.atherosclerosis.2014.01.025. Epub 2014 Jan 23.

PMID:
24530771
9.

Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.

Prieto LM, González-Tomé MI, Muñoz E, Fernández-Ibieta M, Soto B, Álvarez A, Navarro ML, Roa MÁ, Beceiro J, de José MI, Olabarrieta I, Lora D, Ramos JT; Madrid Cohort of HIV-Infected Mother-Infant Pairs.

BMC Infect Dis. 2014 Dec 24;14:700. doi: 10.1186/s12879-014-0700-3.

10.

Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the CaroVIH Study.

Sainz T, Álvarez-Fuente M, Navarro ML, Díaz L, Rojo P, Blázquez D, de José MI, Ramos JT, Serrano-Villar S, Martínez J, Medrano C, Muñoz-Fernández MÁ, Mellado MJ; Madrid Cohort of HIV-infected children and adolescents integrated in the Pediatric branch of the Spanish National AIDS Network (CoRISPE).

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):42-9. doi: 10.1097/QAI.0b013e3182a9466a.

PMID:
23982657
11.

Rationale, design and organization of the delayed antibiotic prescription (DAP) trial: a randomized controlled trial of the efficacy and safety of delayed antibiotic prescribing strategies in the non-complicated acute respiratory tract infections in general practice.

de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, González González AI, Canellas Criado Y, Hernández Anadón S, Rotaeche del Campo R, Torán Monserrat P, Negrete Palma A, Pera G, Borrell Thió E, Llor C, Little P, Alonso Coello P; Delayed Antibiotic Prescription (DAP) Working Group.

BMC Fam Pract. 2013 May 19;14:63. doi: 10.1186/1471-2296-14-63.

12.

Implementation of occult hepatitis screening in the Spanish cohort of HIV-infected pediatric patients.

Dapena M, Figueras C, Noguera-Julian A, Fortuny C, de José MI, Mellado MJ, Gavilán C, Falcón-Neyra MD, Navarro ML, de Ory SJ, López C, Mayol L, Méndez M, Ciria LM, Coll MT, García L, Nuñez E, Espiau M, Soler-Palacín P.

Pediatr Infect Dis J. 2013 Sep;32(9):e377-9. doi: 10.1097/INF.0b013e31828e9b99.

PMID:
23446444
13.

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children.

PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155. Epub 2012 Dec 17.

14.

A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe).

de Jose MI, Jiménez de Ory S, Espiau M, Fortuny C, Navarro ML, Soler-Palacín P, Muñoz-Fernandez MA; working groups of CoRISpe and HIV HGM BioBank.

BMC Infect Dis. 2013 Jan 2;13:2. doi: 10.1186/1471-2334-13-2.

15.

Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007.

Prieto LM, González-Tomé MI, Muñoz E, Fernández-Ibieta M, Soto B, Del Rosal T, Cuadrado I, Navarro ML, Roa MA, Beceiro J, de José MI, Santos MJ, Lora D, Ramos JT; Madrid Cohort of HIV-Infected Mother-Infant Pairs.

Pediatr Infect Dis J. 2012 Oct;31(10):1053-8.

PMID:
22926219
16.

Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.

Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M, Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N.

Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.

PMID:
22828645
17.

High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.

Briz V, García D, Méndez-Lagares G, Ruiz-Mateos E, de Mulder M, Moreno-Pérez D, Navarro ML, León-Leal JA, de José MI, Ramos JT, Mellado MJ, González-Tomé MI, Leal M, Muñoz-Fernández MA.

Pediatr Infect Dis J. 2012 Oct;31(10):1048-52.

PMID:
22828644
18.

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A.

Pediatr Infect Dis J. 2012 Nov;31(11):e213-21. doi: 10.1097/INF.0b013e3182678c7c.

PMID:
22785049
19.

[New diagnosis of HIV infection in children].

Guillén S, Prieto L, Jiménez de Ory S, González-Granado I, González-Tomé MI, Mellado MJ, de José M, Navarro ML, Beceiro J, Roa MÁ, Muñoz MÁ, Tomás Ramos J; en nombre de la Cohorte de Niños Infectados de la Comunidad de Madrid.

Enferm Infecc Microbiol Clin. 2012 Mar;30(3):131-6. doi: 10.1016/j.eimc.2011.09.007. Epub 2011 Nov 25. Spanish.

PMID:
22119095
20.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children.

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk